312 related articles for article (PubMed ID: 22444587)
21. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
22. Structural, morphological, and functional diversity of amyloid oligomers.
Breydo L; Uversky VN
FEBS Lett; 2015 Sep; 589(19 Pt A):2640-8. PubMed ID: 26188543
[TBL] [Abstract][Full Text] [Related]
23. Amyloid fibril formation by human stefins: Structure, mechanism & putative functions.
Zerovnik E; Staniforth RA; Turk D
Biochimie; 2010 Nov; 92(11):1597-607. PubMed ID: 20685229
[TBL] [Abstract][Full Text] [Related]
24. Can misfolded proteins be beneficial? The HAMLET case.
Pettersson-Kastberg J; Aits S; Gustafsson L; Mossberg A; Storm P; Trulsson M; Persson F; Mok KH; Svanborg C
Ann Med; 2009; 41(3):162-76. PubMed ID: 18985467
[TBL] [Abstract][Full Text] [Related]
25. Structures of soluble amyloid oligomers from computer simulations.
Melquiond A; Mousseau N; Derreumaux P
Proteins; 2006 Oct; 65(1):180-91. PubMed ID: 16894607
[TBL] [Abstract][Full Text] [Related]
26. A universal method for detection of amyloidogenic misfolded proteins.
Yam AY; Wang X; Gao CM; Connolly MD; Zuckermann RN; Bleu T; Hall J; Fedynyshyn JP; Allauzen S; Peretz D; Salisbury CM
Biochemistry; 2011 May; 50(20):4322-9. PubMed ID: 21539296
[TBL] [Abstract][Full Text] [Related]
27. Chemical strategies for controlling protein folding and elucidating the molecular mechanisms of amyloid formation and toxicity.
Butterfield S; Hejjaoui M; Fauvet B; Awad L; Lashuel HA
J Mol Biol; 2012 Aug; 421(2-3):204-36. PubMed ID: 22342932
[TBL] [Abstract][Full Text] [Related]
28. Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms.
Liu T; Bitan G
ChemMedChem; 2012 Mar; 7(3):359-74. PubMed ID: 22323134
[TBL] [Abstract][Full Text] [Related]
29. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
[TBL] [Abstract][Full Text] [Related]
30. Drug targets for amyloidosis.
Kolstoe SE; Wood SP
Biochem Soc Trans; 2010 Apr; 38(2):466-70. PubMed ID: 20298204
[TBL] [Abstract][Full Text] [Related]
31. Rapid photochemical cross-linking--a new tool for studies of metastable, amyloidogenic protein assemblies.
Bitan G; Teplow DB
Acc Chem Res; 2004 Jun; 37(6):357-64. PubMed ID: 15196045
[TBL] [Abstract][Full Text] [Related]
32. Cell toxicity and conformational disease.
Carrell RW
Trends Cell Biol; 2005 Nov; 15(11):574-80. PubMed ID: 16202603
[TBL] [Abstract][Full Text] [Related]
33. Protein misfolding, functional amyloid, and human disease.
Chiti F; Dobson CM
Annu Rev Biochem; 2006; 75():333-66. PubMed ID: 16756495
[TBL] [Abstract][Full Text] [Related]
34. Directing the secondary structure of polypeptides at will: from helices to amyloids and back again?
Pagel K; Vagt T; Koksch B
Org Biomol Chem; 2005 Nov; 3(21):3843-50. PubMed ID: 16239998
[TBL] [Abstract][Full Text] [Related]
35. Metal-dependent generation of reactive oxygen species from amyloid proteins implicated in neurodegenerative disease.
Allsop D; Mayes J; Moore S; Masad A; Tabner BJ
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1293-8. PubMed ID: 19021543
[TBL] [Abstract][Full Text] [Related]
36. Protein misfolding in neurodegenerative diseases.
Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM
Neuropathol Appl Neurobiol; 2004 Jun; 30(3):215-24. PubMed ID: 15175075
[TBL] [Abstract][Full Text] [Related]
37. Diseases of protein conformation: what do in vitro experiments tell us about in vivo diseases?
Buxbaum JN
Trends Biochem Sci; 2003 Nov; 28(11):585-92. PubMed ID: 14607088
[TBL] [Abstract][Full Text] [Related]
38. [Amyloidosis: a model of misfolded protein disorder].
Grateau G; Verine J; Delpech M; Ries M
Med Sci (Paris); 2005; 21(6-7):627-33. PubMed ID: 15985206
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of amyloid formation.
Härd T; Lendel C
J Mol Biol; 2012 Aug; 421(4-5):441-65. PubMed ID: 22244855
[TBL] [Abstract][Full Text] [Related]
40. A diversity of assembly mechanisms of a generic amyloid fold.
Eichner T; Radford SE
Mol Cell; 2011 Jul; 43(1):8-18. PubMed ID: 21726806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
